Anne M. Hubbard
YOU?
Author Swipe
View article: Commissioning of a reference beam model-based Monte Carlo dose calculation algorithm for cranial stereotactic radiosurgery
Commissioning of a reference beam model-based Monte Carlo dose calculation algorithm for cranial stereotactic radiosurgery Open
Validation testing demonstrated good agreement between the reference beam dataset and machine performance for targets with diameters ≥7 mm. The use of a reference beam model may significantly reduce measurement burden while mitigating pote…
View article: Improving dose delivery in non‐coplanar cranial SRS: Stereoscopic x‐ray‐guided mitigation of table walkout errors
Improving dose delivery in non‐coplanar cranial SRS: Stereoscopic x‐ray‐guided mitigation of table walkout errors Open
Purpose Linear accelerator (LINAC)‐based single‐isocenter multi‐target (SIMT) treatment has streamlined the cranial stereotactic radiosurgery (SRS) workflow. Though efficient, SIMT delivery adds additional challenges that should be conside…
View article: Cloud-Based Clonogenics and Cell Migration Guide Nanoparticle Mediated Chemo-Radiotherapy Against Glioblastomas
Cloud-Based Clonogenics and Cell Migration Guide Nanoparticle Mediated Chemo-Radiotherapy Against Glioblastomas Open
Glioblastoma (GBM) is the most aggressive and lethal primary brain tumor. The prognosis for patients diagnosed with GBM remains very poor with the median survival time of only 8 months if nothing is done, and 12 - 15 months if surgery, rad…
View article: Patient Positional Uncertainty and Margin Reduction in Lung Stereotactic Ablative Radiation Therapy Using Pneumatic Abdominal Compression
Patient Positional Uncertainty and Margin Reduction in Lung Stereotactic Ablative Radiation Therapy Using Pneumatic Abdominal Compression Open
Clinical data suggest that the uniform 5.0-mm margin is conservative for our workflow. Using modern techniques such as 4D CT, 4D CBCT, and effective motion management can significantly reduce required margins, and therefore necessary healt…
View article: Erratum to: Fields EC, Erickson B, Hubbard A, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M. Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy. Int J Radiat Oncol Biol Phys 2023;117:1138–1142
Erratum to: Fields EC, Erickson B, Hubbard A, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M. Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy. Int J Radiat Oncol Biol Phys 2023;117:1138–1142 Open
View article: Five‐year evaluation of linear accelerator‐based SRS platform isocentricity
Five‐year evaluation of linear accelerator‐based SRS platform isocentricity Open
Linear accelerator (LINAC)‐based stereotactic radiosurgery (SRS) has become a mainstay in the management of intracranial tumors. However, the high fractional doses and sharp gradients used in SRS place heavy demands on geometric accuracy. …
View article: Erratum to: Fields EC, Erickson B, Hubbard A, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M. Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy. Int J Radiat Oncol Biol Phys 2023;117:1138–1142
Erratum to: Fields EC, Erickson B, Hubbard A, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M. Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy. Int J Radiat Oncol Biol Phys 2023;117:1138–1142 Open
View article: Trends in Utilization and Medicare Spending on Short-Course Radiation Therapy for Breast and Prostate Cancer: An Episode-Based Analysis From 2015 to 2019
Trends in Utilization and Medicare Spending on Short-Course Radiation Therapy for Breast and Prostate Cancer: An Episode-Based Analysis From 2015 to 2019 Open
View article: Cellular Biophysical Markers for Rapid Evaluation of Immune Checkpoint Inhibitors in Radioimmunotherapy Against Glioblastomas
Cellular Biophysical Markers for Rapid Evaluation of Immune Checkpoint Inhibitors in Radioimmunotherapy Against Glioblastomas Open
Cancers of the brain and nervous system account for 1 in every 100 cancer diagnoses in the United States and about 0.3 million diagnoses globally, every year. Surgery, radiotherapy, and chemo-therapy constitute the standard of care. Despit…
View article: Trends in Utilization and Medicare Spending on Shorter vs. Longer Radiotherapy Courses for Breast and Prostate Cancer
Trends in Utilization and Medicare Spending on Shorter vs. Longer Radiotherapy Courses for Breast and Prostate Cancer Open
View article: Leveraging national and global political determinants of health to promote equity in cancer care
Leveraging national and global political determinants of health to promote equity in cancer care Open
Health and politics are deeply intertwined. In the context of national and global cancer care delivery, political forces—the political determinants of health—influence every level of the cancer care continuum. We explore the “3-I” framewor…
View article: Simultaneous Assessment of Reactive Oxygen Species and Radiosensitization of Brain Cancer Cells using Nanoparticle Spectroscopy
Simultaneous Assessment of Reactive Oxygen Species and Radiosensitization of Brain Cancer Cells using Nanoparticle Spectroscopy Open
Nanoparticle-mediated radiation therapy (NPRT) is an emerging modality for radiosensitization of highly resistant cancers such as brain cancers. This is due to the ability of specific nanoparticles (NPs) to increase physical dose depositio…
View article: Development of In Vitro Assays for Advancing Radioimmunotherapy against Brain Tumors
Development of In Vitro Assays for Advancing Radioimmunotherapy against Brain Tumors Open
Glioblastoma (GBM) is the most common primary brain tumor. Due to high resistance to treatment, local invasion, and a high risk of recurrence, GBM patient prognoses are often dismal, with median survival around 15 months. The current stand…
View article: Development of in Vitro Assays for Advancing Radioimmunotherapy Against Brain Tumors
Development of in Vitro Assays for Advancing Radioimmunotherapy Against Brain Tumors Open
Glioblastoma (GBM) is the most common primary brain tumor. Due to high resistance to treatment, local invasion, and high risk of recurrence, GBM patient prognoses are often dismal, with median survival around 15 months. The current standar…
View article: A practical path forward to more patient-centered value assessment
A practical path forward to more patient-centered value assessment Open
To ensure that value assessment accounts for patient needs, we need a better understanding of the outcomes that are most important to patients, write authors from COVIA Health Solutions and the University of Washington School of Pharmacy.
View article: Future of Alternative Payment Models and Big Data Analytics in the Post–COVID-19 Era: Implications for Radiation Oncology
Future of Alternative Payment Models and Big Data Analytics in the Post–COVID-19 Era: Implications for Radiation Oncology Open
View article: Evaluating a General Education Program in Transition
Evaluating a General Education Program in Transition Open
This reflective case study uses one public university example to explore the role of student learning outcomes assessment in the improvement of general education programs. These programs are a universal feature of higher education in the U…